Examining Measurement of Behavioral Neglect Post Stroke
Studieoversikt
Status
Forhold
Detaljert beskrivelse
Many individuals have difficulty attending to the affected side of their body or to the affected side of space after stroke (unilateral neglect). Although a number of clinical assessments are used to measure this inattention, it is unclear whether items from some of the most commonly used assessments are able to effectively and comprehensively measure inattention. Clinical assessments provide critical information to clinicians and researchers and are used to inform treatment and document patient progress. Therefore, it is important that investigators more closely examine these existing assessments.
Individuals who demonstrate impaired attention to the affected side after stroke also have greater motor impairment than individuals who do not have impaired attention, but investigators do not know how inattention affects reaching movements using the impaired arm. This study will examine various methods used to assess inattention to the affected side after stroke and also examine how inattention affects reaching movements of the impaired arm.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
South Carolina
-
Charleston, South Carolina, Forente stater, 29425
- Medical University of South Carolina
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Unilateral hemispheric stroke
- 18 years or older
Exclusion Criteria:
- Severe aphasia
- Inability to follow 2-step directions
- Presence of other neurological disease that may impair vision or perception during performance of evaluation procedures
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
|---|
|
Stroke Survivors
Individuals who have experienced a unilateral hemispheric stroke
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Catherine Bergego Scale
Tidsramme: One-time assessment scheduled over 1-2 days
|
One-time assessment scheduled over 1-2 days
|
|
Behavioral Inattention Test
Tidsramme: One-time assessment scheduled over 1-2 days
|
One-time assessment scheduled over 1-2 days
|
|
Naturalistic Action Test
Tidsramme: One-time assessment scheduled over 1-2 days
|
One-time assessment scheduled over 1-2 days
|
|
Virtual Reality Lateralized Attention Test
Tidsramme: One-time assessment scheduled over 1-2 days
|
One-time assessment scheduled over 1-2 days
|
|
Kinematic Assessment of Arm Movement
Tidsramme: One-time assessment scheduled over 1-2 days
|
One-time assessment scheduled over 1-2 days
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Arm Use measured by Accelerometers
Tidsramme: One-time assessment scheduled over 3 days
|
Accelerometers will be issued on the first assessment day.
Participants will wear accelerometers for 3 days.
|
One-time assessment scheduled over 3 days
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Michelle Woodbury, PhD, OTR/L, Medical University of South Carolina
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- PR00044531
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .